Background Recent studies have suggested an association between high dietary intake of calcium and the risk of prostate cancer. Calcium-rich diet has been suggested to affect the serum levels of Vitamin D, and thereby promote cancer. We conducted the largest study of the association between prediagnostic serum levels of calcium and the risk of prostate cancer. Outline We examined the incidence of prostate cancer in relation to prediagnostic serum calcium levels in a prospective cohort study of 22,391 healthy Swedish men, of which 1,539 incident cases of prostate cancer were diagnosed during the 30 years of follow-up until December 2006. Material and methods Serum levels of calcium were measured at baseline, and categorized into quartiles. Cox regression was used to estimate the adjusted hazard ratios (HR) with 95% confidence intervals (CI). Results We found no evidence of an association between prediagnostic serum levels of calcium and risk of prostate cancer (HR for trend = 0.99 [95% CI;0.94-1.03]). However, a moderate significant negative association was seen in men with a BMI above 25 and aged below 45 years at baseline (Highest vs. lowest quartile, HR = 0.63 [95% CI;0.40-0.99]). Conclusion These data do not support the hypothesis that high serum calcium levels is a risk factor for prostate cancer. On the contrary, the data suggest that high serum levels of calcium in young overweight men may be a marker for a decreased risk of developing prostate cancer.
Introduction
Prostate cancer is one of the most common cancers affecting men worldwide, and the most common cancer in men in Europe and the United States. Many possible risk factors have been identified, both endogenous factors such as ethnicity and genes, and exogenous factors such as diet and latitude of residence [1] . However, the etiology of prostate cancer for most parts still remains unknown.
Many studies suggest that a high intake of dietary calcium, such as dairy products, may increase the risk of prostate cancer [2] [3] [4] [5] . A recent meta-analysis of 12 studies comprising approximately 450,000 individuals reported a moderate association between dietary calcium intake and the risk of prostate cancer (highest vs. lowest quartile, RR = 1.39 [95% CI = 1.09-1.77], p = 0.018) [6] .
Serum calcium is believed to be tightly regulated through the mechanism of calcium homeostasis and not easily affected by the dietary intake of calcium. In 1998 Giovannucci presented the hypothesis that a high intake of calcium causes cancer by forcing the body to lower the levels of the tumor suppressing hormone Vitamin D (1,25(OH) 2 D) to prevent hypercalcemia [7] .
Vitamin D is a well-known factor in calcium homeostasis controlling the intestinal absorption of calcium. Although we can obtain Vitamin D through the diet, the most potent source is from endogenous production stimulated by ultraviolet radiation from the sun (UVB). Vitamin D deficiency is also a well-established risk factor for prostate cancer, first proposed by Schwartz et al. [8] in 1990, thereby explaining both the increased risk of prostate cancer at northern latitudes and among men with dark or elderly skin.
Despite the observed association between high calcium intake and prostate cancer, only two studies have previously examined the association between serum levels of calcium and the risk of prostate cancer [9, 10] . These studies were fairly small, only 85 incident cancers with an average follow-up time of less than 10 years. They did not find evidence of an association with risk of incident prostate cancer, but they found that serum calcium was associated with the risk of fatal prostate cancer.
Studies looking at the association between dietary calcium intake and subsequent levels of Vitamin D are inconclusive [3, [11] [12] [13] [14] . In a recent review article, the authors conclude that there is no sufficient support for a causal association between high calcium intake and low levels of Vitamin D [15] . This may possibly be a result of differences in maintaining normal levels of serum calcium, but studies of prediagnostic levels of Vitamin D and the risk of prostate cancer, the latter section of the pathway, are also inconclusive [14, [16] [17] [18] [19] [20] [21] .
An association between prediagnostic serum levels of calcium and the subsequent risk of breast cancer was found to be modified by the Body Mass Index (BMI) [22] , and the association between the calcium-regulating factor Vitamin D and the risk of prostate cancer has been suggested to be modified by age [17] . That is, the relation among calcium, Vitamin D, and the risk of prostate cancer may be different in subgroups defined by age and BMI.
Our primary aim was to investigate the incidence of prostate cancer in relation to the prediagnostic serum calcium levels in a prospective study of 22,391 healthy Swedish men. An additional aim was to examine whether this association was modified by age and BMI.
Materials and methods

Malmö preventive project
The Malmö Preventive Project (MPP) in Malmö, Sweden, was established in 1974 for screening entire birth-year cohorts with regard to general health and, specifically, cardiovascular risk factors [23] . The study invited selected birth-year cohorts of men residents born in Malmö between 1920 and 1945. Overall, 22,444 men attended the baseline examination, corresponding to a participation rate of approximately 75% [23] . Malmö is the third largest city of Sweden, situated on the southwestern coast, with a population of approximately 280,000 citizens.
Baseline examination
All participants completed a self-administered questionnaire on lifestyle and medical history [23] . The following available factors in the questionnaire were considered as possible confounders: age at entry (date of birth), alcohol consumption, and smoking status. The questionnaire included seven detailed questions on alcohol behavior, and the alcohol consumption was assessed using a modified version of the Michigan Alcoholism Screening Test [24] , referred to as the Mm-MAST [25, 26] . Smoking status was classified as ''never,'' ''former,'' or ''current'' according to the questions: ''Do you smoke?'', and ''Have you ever smoked for a period of six months or more?''. A trained nurse measured height and weight at entry, which was used to calculate the Body Mass Index (BMI) (kg/m 2 ). Socioeconomic status was classified according to the Swedish ''Socioeconomic Index'' (SEI). This information, and marital status, was obtained from the 1980 Swedish Population and Housing Census [27] . Five percent of all participants had no census data on SEI from 1980; four percent due to partial completion of the census, a half percent due to non-participation in the census, and another half percent which had participated in the cohort, but died prior to 1980.
Serum calcium measurements
Study participants had fasted overnight after which a team of trained nurses took blood samples. These were immediately analyzed for calcium at the Department of Clinical Chemistry, University Hospital of Malmö, Sweden. Three different instruments were used for calcium analysis during the time of the study: From 1974 until 1979, the department used flame atomic emission spectroscopy with a flame photometry from Techicon (method 1). From 1979, a molecular absorption spectrophotoscopy instrument from Vitatron was used (method 2). In December 1980, this was replaced by a similar instrument (PRISMA multichannel autoanalyser, Clinicon AB, Sweden) (method 3 
Statistical analyses
This study was analyzed using standard methods for the analysis of cohort studies (survival analysis). Person-years were calculated for each individual from his entry to cohort until the diagnosis of prostate cancer, death, or end of follow-up. In order to estimate the association between prediagnostic calcium levels and the risk of prostate cancer, we used Cox proportional hazards regression, yielding hazard ratios (HR) with 95% confidence intervals (CI). The timescale in all Cox analyses was the time since the entry, with the underlying time-unit in days.
Analyses were adjusted for age at entry as a continuous variable. All other covariates were entered as categorical (Table 4) were performed by stratifying on age at entry to the cohort (categorized as younger than 45, and 45 or older), and BMI (less than 25, and 25 or more), and then adjusting for age at entry as a continuous variable within each Cox model. Serum levels of calcium were modeled in quartiles (the lowest quartile being the reference category), and a test for a linear trend over quartile categories was analyzed by scoring quartiles as 1 through 4. In order to examine possible divergence between the three different instruments used for the calcium analyses over the study period, the calcium quartile distribution was plotted by year of entry. The distribution was the same for the first two instruments, both used before December 1980 (referred to as period 1), but different for the third instrument, installed and used from December 1980 (referred to as period 2). Due to differences between the instruments, we made two different quartile definitions: one for samples analyzed before December 1980 (analyzed on instrument 1, and later instrument 2) and one for the latter (analyzed on instrument 3 after December 1980). Hence, the calcium level intervals for the quartiles are different depending on which calendar period they refer to, but the distributions are similar over time.
Since some of the covariates had a rather substantial number of cases with no information, the impact of this missingness was estimated in several ways. First, only subjects with complete information on all covariates were included. Second, missing values were modelled as a separate category, i.e., the missing indicator method. Third, and finally, a sensitivity analysis was performed to determine the possible effect of missingness of alcohol status and socioeconomic index (SEI). Extreme values were imputed for the missing categories generating four models: alcohol as low consumer and SEI as manual worker, alcohol as low consumer and SEI as non-manual worker, alcohol as high consumer and SEI as manual worker, and alcohol as high consumer and SEI as non-manual worker. All these models were adjusted for age at entry, smoking status, marital status, and BMI with missing as separate categories.
All analyses were repeated excluding incident prostate cancers diagnosed within two years following baseline examination to explore the possibility of a confounding effect of undiagnosed tumors affecting the serum calcium levels at baseline. All analyses were also repeated excluding all other incident cancers diagnosed within two years following baseline examination. These analyses did not affect the estimates substantially.
All statistical analyses were performed using the SPSS software [29, 30] .
Results
Men in the highest serum calcium quartile were comparatively young as compared to lower quartiles ( Table 1 ). The distribution of former and never smokers was similar over quartiles, but the proportion of current smokers was relatively low in the fourth calcium quartile. The distribution of body mass index (BMI), alcohol consumption, marital status, and socioeconomic index (SEI) was similar in all calcium quartiles. The proportion of missing values was equally distributed between quartiles for all factors (Table 1) . Men subsequently diagnosed with prostate cancer, as compared to the rest of the cohort, were older at entry and more likely to be current smokers, married, and non-manual workers (Table 2 ). They were also more likely to have been analyzed in the first period as compared to rest of the cohort. Moreover, the proportion of former smokers was lower in men later diagnosed with prostate cancer compared to the rest of the cohort, and they were less likely to have answered all the questions on alcohol behavior. They had, however, completed the population census relatively more often than the rest of the cohort. The total number of person-years was 544,429 with an average follow-up of 24.3 years. The mean follow-up for only those diagnosed with cancer was 21.3 years (95% CI: 21.0-21.5, SD 0.134), and for those free of prostate cancer throughout the study, it was 24.5 years (95% CI 24.45-24.62, SD 0.044). Table 3 shows the association between serum calcium levels and prostate cancer, which was not statistically significant. There were no major differences between hazard ratios derived from the entire cohort as compared to subjects with complete data on all potential confounders ( Table 3) . The model including all covariates using the missing indicator method produced similar hazard ratios as compared to corresponding hazard ratios for the entire cohort as well as all analyses restricted only to complete cases. In addition, the sensitivity analysis showed that imputation of extreme values for alcohol consumption and socioeconomic index did not substantially affect the results.
Neither the sensitivity analyses nor the complete subjects model differed notably from the missing indicator model, suggesting any potential bias caused by incomplete data is not large.
Then, we investigated the modifying effects of BMI and age on the relationship between serum calcium and risk of prostate cancer. High calcium levels were negatively associated with the risk of prostate cancer in men who entered the study younger than 45 years of age and with a BMI of 25 or more. No other statistically significant associations were seen in any stratum of age and BMI (Table 4) .
When excluding all cases diagnosed with prostate cancer within two years after baseline examination, all hazard ratios remained similar (HR for trend = 0.98; 95% CI: 0.94-1.03) per quartile of serum calcium (data not shown). When also excluding subjects diagnosed with any cancer within two years of baseline examination, the hazard ratios did not change noticeably and the trend remained the same (data not shown).
Discussion
In this population-based cohort comprising 22,391 Swedish men, we did not find evidence supporting a serum calcium pathway in the etiology of prostate cancer. We did not find evidence of an association between prediagnostic serum calcium levels and the risk of prostate cancer. There was, however, some evidence of a small, but significant inverse association in young men with a BMI over 25.
Many studies have suggested that a high intake of calcium may increase the risk of prostate cancer. A recent meta-analysis of 12 large studies of intake of calcium and dairy products concluded that there is a small, but positive, association with the risk of prostate cancer [6] . Giovannucci [7] suggested that a high dietary intake of calcium would lead to lower Vitamin D-an established risk factor for prostate cancer. However, even though Ahn et al. [11] c These are four different models, each one categorizing the subjects with missing on alcohol consumption and socioeconomic index to their extremes in four different combinations. Alcohol:low refer to the subjects with missing information on the alcohol consumption variable as being categorized as low consumers. Alcohol:high refer to the subjects with missing information on the alcohol consumption variable as being categorized as high consumers. SEI:manual refer to the subjects with missing information on the socioeconomic index as being categorized as manual workers. SEI:non-manual refer to the subjects with missing information on the socioeconomic index as being categorized as non-manual workers in their study of 29,509 men, including 1,910 cases, found a moderate association between dietary calcium intake and risk of prostate cancer, their study of a subset of 275 individuals in the same study population did not show an association between dietary calcium intake and subsequent levels of Vitamin D. We did, however, find indications of an interaction between serum calcium, body mass index, and age at screening. Serum levels of calcium in the subgroup of young (under 45) and overweight (BMI over 25) were inversely associated with the incidence of prostate cancer. Both BMI and age have been found to affect the calciumregulating hormone Vitamin D [31] , and its relation to the risk of prostate cancer was found to be modified by age [17] . We therefore believe it is reasonable to speculate that age, as well as BMI, might modify the association between serum calcium and prostate cancer risk.
In the parallel population-based cohort study of 7,847 Swedish women in the Malmö Preventive Program, looking at serum calcium levels and breast cancer, there was an association between prediagnostic calcium levels and the risk of breast cancer, and there was also evidence that the association was modified by BMI [22] . The association, both separate and stratified by BMI, was negative in premenopausal women and positive in postmenopausal women, suggesting a modifying effect also by menopausal status. It was thus suggested that this was an effect of hormonal levels and not by age as such. Estrogens have been suggested not only to play a role in the development of breast cancer, but also in the development and progression of prostate cancer [32] . Both estrogens and testosterone have been found to be of importance in regulating bone resorption as well as maintaining bone formation in aging men [33] . Possibly, the modifying effect of BMI and age on the association between serum levels of calcium and subsequent risk of prostate cancer found in our study is explained by differences in the levels of sex steroid hormones between the subgroups. For additional studies of prostate cancer, it could therefore be of relevance to measure also the prediagnostic levels of sex steroids, such as testosterone and estrogens.
Serum calcium is believed to be tightly regulated and only affected in pathological conditions, such as the presence of calcium-producing/binding tumors, osteoporosis, or severe malnutrition. A single measure of serum calcium at one point in time may not be a perfect reflection of an individuals' long-term dietary calcium intake, and small individual differences might drown in the normal variance. However, fairly small differences in serum levels would be detectable at a group level [9, 10] , especially in a large study such as this of more than 22,000 men and with more than 1,500 prostate cancer cases. Even if so, the association between serum calcium and risk of prostate cancer would not necessarily be an effect of the dietary intake of calcium, but possibly an effect of other dietary risks and/or an imbalance in the calcium-regulating system, such as Vitamin D levels. Nonetheless, we believe that an association between serum calcium and risk of prostate cancer, if it existed, would be noteworthy and very possibly of clinical value.
During the last 20 years, the introduction of the prostate-specific antigen (PSA) screening has enhanced the early detection of prostate cancer with the consequence of a higher proportion of non-fatal cancers among the diagnosed [34] . Unfortunately, the method of detection or the underlying reason for conducting a PSA test is currently not unavailable for the study participants. However, the proportion of screen detected cases among men (\75 years old) in Malmö during 2004 and 2006 was 52% and 43%, respectively [35] [36] [37] . If the association between serum calcium and prostate cancer is more prominent and relevant in fatal prostate cancer, a high proportion of PSA detected cases would dilute the association.
If we assume that the association between serum calcium and prostate cancer only exists for fatal prostate cancer, then we would expect the association between serum calcium and prostate cancer, in general, to be higher among those screened at a young age, where the proportion of fatal prostate cancer is higher.
When analyzing total calcium, as compared to only measuring free ionized calcium (Ca 2? ), the possibility of an anomaly in the proportion of bound calcium in relation to biologically available calcium is not taken into account. If a man were to have, e.g., elevated levels of calciumbinding plasma proteins, typically albumin, then total calcium level would be misguiding. Unfortunately, data on albumin levels are unavailable which precludes the possibility of calculating the amount of free calcium. However, total calcium has been considered as a good measure of calcium homeostasis in outpatients and healthy individuals where albumin will be expected to be in the normal range [38] such as the men in our study. In the parallel population-based cohort study of 7,847 Swedish women in the Malmö Preventive Program, only 3.5% of those with albumin levels (77 out of 2,206 women) had values outside the reference interval of 36-45 g/l [39] . Moreover, all samples were handled in a standardized manner, which minimizes differences in albumin levels due to fasting status or diurnal variation [40] .
Unfortunately, the coefficient of variance was unavailable for two of the three methods used to analyze the serum calcium levels during the course of the study. However, the variance of serum calcium between screening periods ranged from 3.1% to 3.6%, suggesting that an underestimation of the association due to non-differential misclassification appears unlikely.
Secondary hypercalcemia or hypocalcemia due to bone or bony metastases present a possible bias when looking at calcium levels in relation to cancer. However, when excluding all subjects diagnosed with any cancer within two years after baseline examination, the results were similar. Early serum calcium-altering tumors in undiagnosed prostate cancer cases hiding a true association would most likely have been discovered by such an exclusion.
This study examined healthy Swedish men, all willing to participate in a health study in the 1970s. The men were found to be healthier and with a lower mortality than those who chose not to participate [41] . Yet, the participation rate was high, and the baseline examination was conducted approximately 25 years prior to diagnosis. This together with several validation studies of the Malmö Preventive Project makes it reasonable to assume that the men of this study represent the Swedish male population.
Swedish men are, though light-skinned, habitants of a country underprivileged in sun hours and therefore not expected to have a high serum level of Vitamin D. If the association between serum calcium and prostate cancer is mediated by serum levels of Vitamin D, this should be taken into consideration.
This study did not include information on cancer grade or stage, which would have been a valuable aspect since other studies have shown a stronger association between calcium and advanced and/or fatal prostate cancer.
This study has only examined serum calcium, and although prediagnostic, such data do not provide extremely strong support for a causative association with a pathway via the serum calcium levels.
Given the evidence of a possible association with the biological mechanism involving the calcium homeostasis, it would be recommended to also look at the serum levels of insulin, Vitamin D, sex steroids, and parathyroid hormone, especially in relation to fatal prostate cancer. Furthermore, information on sun exposure, physical activity [42] , and dietary intake of calcium, especially dairy products, would have been valuable. However, this information was unfortunately not available.
Conclusions
In this prospective study of 22,391 healthy Swedish men, we found no support for the hypothesis of high serum calcium levels being an intermediate in the proposed biological causal pathway between dietary calcium intake and risk of prostate cancer. However, we did find indications of a small, but significant association in a subanalysis of the strata with men who were younger than 45 years of age, and who had a BMI of more than 25 at baseline. This might indicate a novel three-way interaction between BMI, age, and calcium serum level with the risk of prostate cancer, possible related to the Vitamin D status.
